Tag:
Nobel Biocare
Latest Headlines
Latest Headlines
Nobel sees European revenues decline in Q3
Nobel Biocare ( $NOBN ), a Swiss dental solutions company, saw a net loss of roughly €2.2 million--or just under $3 million--during the third quarter as revenue in the Europe, Middle East and
Nobel Biocare rises on buyout talks
Switzerland's Nobel Biocare rose the most in more than two years after reports emerged saying EQT Partners AB and Bain Capital are eyeing the dental-implant maker. EQT, a Swedish private equity
Synthes vet tapped as next Nobel Biocare chair
Michel Orsinger, president and CEO of Synthes, is slated to become the next chairman of the board of Nobel Biocare after current Chairman Heino von Prondzynski announced his intention to resign.
Nobel Biocare Q1 profit dips, submits bid for Astra Tech
Switzerland's Nobel Biocare Holding says Q1 profit fell 67 percent versus the same period last year; however, it still wants to buy AstraZeneca's Astra Tech dental implant business. According to its
